Reply
Jennifer R. Kramer, Yamini Natarajan, Jianliang Dai, Xian Yu, Liang Li, Hashem B. El‐Serag, Fasiha Kanwal – 1 April 2022
Src homology 3 domain binding kinase 1 protects against hepatic steatosis and insulin resistance through the Nur77–FGF21 pathway
Palak Ahuja, Xinyi Bi, Chun Fai Ng, Margaret Chui Ling Tse, Miaojia Hang, Brian Pak Shing Pang, Elsie Chit Yu Iu, Wing Suen Chan, Xin Ci Ooi, Anqi Sun, Oana Herlea‐Pana, Zhixue Liu, Xiuying Yang, Baowei Jiao, Xin Ma, Kelvin Ka Lok Wu, Leo Tsz On Lee, Kenneth King Yip Cheng, Chi Wai Lee, Chi Bun Chan – 31 March 2022
Are there outcome differences between NAFLD and metabolic‐associated fatty liver disease?
Zobair M. Younossi, James M. Paik, Reem Al Shabeeb, Pegah Golabi, Issah Younossi, Linda Henry – 31 March 2022
Reply
Jessica Musto, Michael R. Lucey, John Rice – 31 March 2022
Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017–2018 transient elastography data and application of machine learning
Mazen Noureddin, Fady Ntanios, Deepa Malhotra, Katherine Hoover, Birol Emir, Euan McLeod, Naim Alkhouri – 31 March 2022 – This cohort analysis investigated the prevalence of nonalcoholic fatty liver disease (NAFLD) and NAFLD with fibrosis at different stages, associated clinical characteristics, and comorbidities in the general United States population and a subpopulation with type 2 diabetes mellitus (T2DM), using the National Health and Nutrition Examination Survey (NHANES) database (2017–2018).
An international survey on patterns of practice in NAFLD and expectations for therapies—The POP‐NEXT project
Vlad Ratziu, Quentin M. Anstee, Vincent Wai‐Sun Wong, Jörn M. Schattenberg, Elisabetta Bugianesi, Salvador Augustin, Liana Gheorghe, Vittoria Zambon, Nancy Reau – 31 March 2022
Achieving Equity for Liver Transplantation Recipients With Chronic Kidney Disease
Darshana M. Dadhania, Mona D. Doshi – 30 March 2022
Variability in serum creatinine is associated with waitlist and post–liver transplant mortality in patients with cirrhosis
Giuseppe Cullaro, Chi‐yuan Hsu, Jennifer C. Lai – 30 March 2022
Analysis of direct‐acting antiviral‐resistant hepatitis C virus haplotype diversity by single‐molecule and long‐read sequencing
Kozue Yamauchi, Mitsuaki Sato, Leona Osawa, Shuya Matsuda, Yasuyuki Komiyama, Natsuko Nakakuki, Hitomi Takada, Ryo Katoh, Masaru Muraoka, Yuichiro Suzuki, Akihisa Tatsumi, Mika Miura, Shinichi Takano, Fumitake Amemiya, Mitsuharu Fukasawa, Yasuhiro Nakayama, Tatsuya Yamaguchi, Taisuke Inoue, Shinya Maekawa, Nobuyuki Enomoto – 30 March 2022 – The method of analyzing individual resistant hepatitis C virus (HCV) by a combination of haplotyping and resistance‐associated substitution (RAS) has not been fully elucidated because conventional sequencing has only yielded short and fragmented viral ge
LKB1 acts as a critical brake for the glucagon‐mediated fasting response
Suehelay Acevedo‐Acevedo, Megan L. Stefkovich, Sun Woo Sophie Kang, Rory P. Cunningham, Constance M. Cultraro, Natalie Porat‐Shliom – 30 March 2022 – As important as the fasting response is for survival, an inability to shut it down once nutrients become available can lead to exacerbated disease and severe wasting. The liver is central to transitions between feeding and fasting states, with glucagon being a key initiator of the hepatic fasting response. However, the precise mechanisms controlling fasting are not well defined.